"No swift action" on US CBD regulation after FDA comments, warns analyst

Home › "No swift action" on US CBD regulation after FDA comments, warns analyst

CBD beverage producers in the US may have to wait for clarity on regulation as authorities look set to miss a February deadline, an analyst has said.

11.01	The FTSE 100 has hit a record high. Is now the time to start investing?
11.01	The FTSE 100 has hit a record high. Is now the time to start investing?
11.01	'I had no electricity for six months': American families struggle with soaring energy prices
11.01	'I had no electricity for six months': American families struggle with soaring energy prices
11.01	The real impact of roadworks on the country - and why they're set to get worse
11.01	Google employee made redundant after reporting sexual harassment, court hears
10.01	This Week in Agribusiness, January 10, 2026
10.01	This Week in Agribusiness, January 10, 2026
More »

je.st